Keto diet reduces liver fat by 67% in obese clinical trial

A recent clinical trial has found that a ketogenic diet significantly reduced liver fat by 67% among participants, outperforming both Mediterranean and low-fat diets. The study involved individuals dealing with obesity, prediabetes, and fatty liver disease. Participants on the keto diet experienced these substantial health benefits over a period of four to five months.

This trial is timely as obesity and related metabolic disorders are on the rise globally. With an increasing number of people affected by prediabetes and fatty liver disease, effective dietary interventions are critical. The research compared three dietary approaches, allowing scientists to evaluate their impacts on metabolic health. While all three groups saw similar weight loss of about 10%, the keto diet's ability to target liver fat sets it apart.

Approximately half of the participants on the ketogenic diet no longer met the criteria for prediabetes after the study period. This suggests that the keto diet not only aids in weight management but also has the potential to reverse prediabetes, a condition that can lead to more serious health issues like type 2 diabetes. These findings offer hope for those struggling with metabolic syndrome.

Going forward, these results could encourage more healthcare professionals to recommend the ketogenic diet as a viable option for improving metabolic health. As the research continues, it may lead to broader acceptance of low-carbohydrate diets in clinical settings, potentially transforming dietary guidelines for individuals facing similar health challenges.